FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/03/105320 [Registered on: 03/03/2026] Trial Registered Prospectively
Last Modified On: 03/03/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Dentistry 
Study Design  Other 
Public Title of Study   Effect of Smoking on Bone Changes Around Different Dental Implant Designs 
Scientific Title of Study   Comparative Evaluation Of Crestal Bone Level Changes Between Hydrophobic, Hydrophilic, And Laser Micro-Grooved Dental Implants Using Minimally Invasive Flapless Technique In Smoker Individuals – A Randomised Controlled Clinical Trial.” 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr C ANNE KIRUBA 
Designation  Post graduate resident  
Affiliation  SRM Dental college , Ramapuram  
Address  Department of Periodontics,4th floor PG block,PG clinic,SRM dental college, Bharathi Salai, Ramapuram, chennai, TAMILNADU 600089 INDIA

Chennai
TAMIL NADU
600089
India 
Phone  9442250741  
Fax    
Email  ann20chris@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr PSG Prakash 
Designation  Professor SRMDC 
Affiliation  SRM Dental college , Ramapuram 
Address  Department of Periodontics,4th floor PG block,PG clinic,SRM dental college, Bharathi Salai, Ramapuram, chennai, TAMILNADU 600089 INDIA

Chennai
TAMIL NADU
600089
India 
Phone  9840870990  
Fax    
Email  akashpsg@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr PSG Prakash 
Designation  Professor SRMDC 
Affiliation  SRM Dental college , Ramapuram 
Address  Department of Periodontics,4th floor PG block,PG clinic,SRM dental college, Bharathi Salai, Ramapuram, chennai, TAMILNADU 600089 INDIA

Chennai
TAMIL NADU
600089
India 
Phone  9840870990  
Fax    
Email  akashpsg@gmail.com  
 
Source of Monetary or Material Support  
Department of periodontics, PG block, PG clinic, 4th floor, SRM DENTAL COLLEGE, Bharathi Salai, Ramapuram, Chennai, 600089 
 
Primary Sponsor  
Name  C ANNE KIRUBA  
Address  Dr. Anne Kiruba , 1st yr post graduate student, department of periodontics, PG block, PG clinic, 4th floor, SRM DENTAL COLLEGE, Bharathi Salai, Ramapuram, Chennai, 600089 
Type of Sponsor  Other [self funding ] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr C ANNE KIRUBA  SRM Dental College   Department of periodontics, PG block, 4th floor PG clinic, SRM Dental College , Bharathi Salai, Ramapuram, Chennai 600089
Chennai
TAMIL NADU 
9442250741

ann20chris@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL REVIEW BOARD SRM DENTAL COLLEGE   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K050||Acute gingivitis, (2) ICD-10 Condition: F172||Nicotine dependence,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  control group  smoker Patients with isolated edentulous receiving Hydrophobic implants (Sand blasted large grid acid etched implants- Neoporous surface – SLA)  
Intervention  test group 1  smoker Patients with isolated edentulous receiving Hydrophilic implants (Sand blasted large grid acid etched implants with aqua surface - SLA active)  
Intervention  test group 2  smoker Patients with isolated edentulous receiving Laser Micro Grooved implants (LMG)  
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Patients aged between 25 and 60 years will be included in the study
2. One bounded edentulous space i.e., a single tooth missing with intact proximal teeth primarily in the lower posteriors (premolars and molars) with sufficient bone quantity to allow implant placement.
3. Patients should be cooperative, motivated and oral hygiene conscious.
4. Only patients with adequate bone height of at least 13 mm and bone width of at least 6 mm will be included.
5. Patients with healthy adjacent teeth and stable periodontal status will be considered for inclusion.
6. current smokers were included only if their exposure was classified as mild, defined as fewer than 10 cigarettes per day and a cumulative history of less than 0.5 pack-years.
 
 
ExclusionCriteria 
Details  1. Patients with uncontrolled systemic diseases such as diabetes, immunocompromised conditions, or bleeding disorders.
2. Patients who have a history of taking bisphosphonates, corticosteroids, immunosuppressive drugs, or anticoagulants will be excluded.
3. Patients with active periodontal disease or untreated oral infections will be excluded.
4. Patients who require bone grafting or ridge augmentation procedures will be excluded.
5. Patients exhibiting parafunctional habits such as bruxism or clenching will be excluded.
6. Pregnant or lactating women will be excluded from the study.
7. Patients who have undergone radiotherapy in the head and neck region or chemotherapy will be excluded.
8. Patients with known allergy to titanium or implant-related materials will be excluded.
9. Patients who are unwilling or unable to comply with oral hygiene instructions will be excluded.
10. Patients with a history of failed implant placement at the intended site will be excluded.
11. Patients who do not comply for 1 year follow up are excluded 
 
Method of Generating Random Sequence   Permuted block randomization, fixed 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
1) Mean Crestal bone level changes (mm) to be assessed at Baseline and 1 year with standardized Intra oral periapical radiographs in Control (SLA) and Test groups (SLA-Active & LMGI).
2) Implant survival rates (%) to be assessed at 1 year with radiographic and clinical assessment between Control (SLA) and Test groups (SLA Active & LMGI).
 
baseline and 1 year 
 
Secondary Outcome  
Outcome  TimePoints 
1. To evaluate and compare the Relative position of gingival margin (mm) at the implant site of Control (SLA) and Test groups (SLA-Active and LMGI) at Baseline, 6 months and 1 year post loading  baseline , 6 months and 1 year 
2. To assess the Implant stability quotient (ISQ) values using resonance frequency analysis (RFA) during Early Loading protocol.
3. To assess the Early Wound Healing Index (EWHI) using Huang et al index (2005) at the 1st week, 2nd week, and 4th week during the Early Loading protocol, comparing the Control (Hydrophobic) and Test groups (Hydrophilic and Laser Micro-Grooved Implants).
4. To assess and compare Patient Reported Outcome Measures (PROMs) like pain scale using Visual Analog Scale at 1 week
 
1st week, 2nd week, 4th week, 6 months and 1 year 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   31/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study evaluates how microgeometrical surface modification of dental implants impacts stability, crestal bone preservation, peri-implant health, and implant survival, particularly in smoker patients. These findings will provide insights to optimize implant selection, treatment planning, and patient care, contributing to improved long-term success and patient outcome.  
Close